Summary: Neurocrine Biosciences discussed in Motley Fool Scoreboard episode, not in top 10 stock picks.

From Nasdaq, Inc.: 2025-03-26 19:00:00

Neurocrine Biosciences (NASDAQ: NBIX) is highlighted in a Motley Fool Scoreboard episode, offering insights into market trends and potential investment opportunities. Stock prices used were from Feb. 19, 2025, and the video was published on March 26, 2025. The Motley Fool Stock Advisor team identified the 10 best stocks to buy now, with Neurocrine Biosciences not making the cut. Consider joining Stock Advisor for a blueprint for success and access to top stock picks. Stock Advisor returns have outperformed the S&P 500 since 2002. Don’t miss out on the latest top 10 list.



Read more at Nasdaq, Inc.: Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential